# Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

> **NCT00666328** · PHASE3 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 37 (actual)

## Conditions studied

- Hypertension
- Hemorrhage

## Interventions

- **DRUG:** clevidipine

## Key facts

- **NCT ID:** NCT00666328
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666328, "Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00666328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*